CAI Q3 2017 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M+14.9% YoY

Gross Profit

$45M49.4% margin

Operating Income

$30M33.5% margin

Net Income

$18M19.5% margin

EPS (Diluted)

$0.90

QoQ Revenue Growth

+9.0%

Cash Flow

Operating Cash Flow

$40M

Free Cash Flow

-$110M

Stock-Based Comp.

$544,000

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.9B

Stockholders' Equity

$499M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$78M	+14.9%
Gross Profit	$45M	$31M	+45.7%
Operating Income	$30M	$11M	+182.9%
Net Income	$18M	-$5M	+424.8%